Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.745 USD | -0.95% | +6.64% | +28.08% |
May. 07 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
May. 07 | Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.08% | 435M | |
+75.73% | 12.57B | |
-26.07% | 7.42B | |
+8.05% | 6.74B | |
+11.63% | 5.34B | |
-15.78% | 4.78B | |
+29.47% | 4.62B | |
-24.82% | 3.69B | |
-22.64% | 2.9B | |
+48.16% | 2.37B |
- Stock Market
- Equities
- BVS Stock
- News Bioventus Inc.
- Morgan Stanley Adjusts Price Target on Bioventus to $5 From $11, Maintains Overweight Rating